AI Multi-Horizon Analysis
Lack of intraday technical data prevents a confident assessment. Price action around the insider selling zone ($187-$192) will be key.
Mixed signals from insider selling versus underlying financial strength. The $187-$192 range is a key area to watch for potential resistance. A break above $192 could signal continuation, while a fall below $180 might indicate short-term weakness.
Fundamentally sound with a strong capital base, consistent earnings growth (despite Q2 dip), and ongoing share buybacks. Diversified business model provides resilience. Long-term trend remains bullish, with pullbacks offering accumulation opportunities.
Morgan Stanley exhibits strong fundamentals with growing capital and earnings, but significant insider selling at current levels introduces near-term caution. Long-term prospects remain positive, supported by consistent buybacks and a diversified business model. The lack of technical data limits short-term directional conviction.
Detailed AI Fundamental Analysis
Morgan Stanley (MS) – Fundamental Briefing
Ticker: MS | Type: Common Stock | Exchange: NYSE | Price: $188.68
CIK: 0000895421 | Market Cap: $299.1B | Employees: 83,000 | Listed: 1986
Business Snapshot
Morgan Stanley is a global financial services firm classified under the Security Brokers, Dealers & Flotation Companies sector. Its core businesses include investment banking, wealth management, institutional securities, and investment management. With $1.42 trillion in total assets (Dec 2025) and a market cap of nearly $300B, it is one of the largest diversified financial institutions in the U.S.
Financial Trends (4‑Period Trajectory)
All figures sourced from the last four SEC filings (Mar, Jun, Sep, Dec 2025). The 2025-12-31 filing is the annual 10‑K; prior periods are 10‑Qs.
Net Income & EPS
| Period | Net Income | Basic EPS | Diluted EPS |
|---|---|---|---|
| Mar 2025 (Q1) | $4,315M | $2.62 | $2.60 |
| Jun 2025 (Q2) | $3,539M | $2.15 | $2.13 |
| Sep 2025 (Q3) | $4,610M | $2.83 | $2.80 |
| Dec 2025 (FY) | $16,861M | $10.32 | $10.21 |
- Trajectory: Net income fell ~18% from Q1 to Q2, then surged ~30% from Q2 to Q3. Q4 (implied from the four‑quarter total) is approximately $4,397M — a 4.6% decline from Q3 but still well above the Q2 trough.
- The full‑year net income of $16.86B reflects a strong rebound in the back half of the year compared to the weak Q2.
Key Delta: Q3 → Q4 net income slipped by about $213M (−4.6%) despite a rising stock price and rate environment. The EPS trajectory mirrors net income, with diluted EPS moving $2.60 → $2.13 → $2.80 → $10.21 (annual). The Q4 implied quarterly EPS is ~$2.69.
Balance Sheet Strength
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Trend |
|---|---|---|---|---|---|
| Total Assets | $1.300T | $1.354T | $1.365T | $1.420T | +9.2% over 4 periods |
| Total Liabilities | $1.192T | $1.245T | $1.254T | $1.308T | +9.7% over 4 periods |
| Shareholders' Equity | $106.8B | $108.2B | $110.0B | $111.6B | +4.5% over 4 periods |
| Cash & Equivalents | $90.7B | $109.1B | $103.7B | $111.7B | +23.1% over 4 periods |
| Retained Earnings | $107.7B | $109.6B | $112.4B | $115.1B | +6.9% over 4 periods |
| Shares Outstanding | 1.607B | 1.598B | 1.591B | 1.583B | −1.5% (buybacks) |
- Assets & Liabilities are growing in lockstep (liabilities up 9.7% vs assets up 9.2% over the four quarters), typical for a broker‑dealer expanding its balance sheet.
- Shareholders’ equity has steadily increased each quarter (+$1.4B → +$1.8B → +$1.7B), supported by retained earnings growth.
- Cash jumped sharply in Q2 (to $109B) and ended the year at a record $111.7B, providing ample liquidity.
- Share buybacks reduced diluted share count by ~24M shares over 9 months, a consistent trend.
Cash Flow (Notable Trends)
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 (FY) |
|---|---|---|---|---|
| Cash from Operations | −$23,976M | −$12,147M | −$15,479M | −$17,889M |
| Cash from Investing | −$5,034M | −$22,706M | −$33,382M | −$46,779M |
| Cash from Financing | +$13,045M | +$34,712M | +$43,788M | +$67,758M |
| Ending Cash | $90,739M | $109,130M | $103,734M | $111,695M |
- Operating cash flow is deeply negative each period, which is characteristic of a firm that uses trading assets/liabilities as working capital. The negative CFO does not indicate distress; it reflects the expansion of trading inventory and collateral.
- Investing cash flow became progressively more negative as the firm deployed cash into securities and loans.
- Financing cash flow was the dominant source, rising from $13B to $68B (annual), driven by new debt and equity‑linked issuances.
- Free cash flow is not reported and is not a meaningful metric for a broker‑dealer due to the nature of its operations.
Margins & Other Ratios
- Gross, Operating, and Net margins are not provided in the data. Net margin can be inferred from the full‑year: Net income of $16.86B divided by revenue (not given) — but revenue data is absent, so profit margin trajectory cannot be assessed.
- Debt/Equity and Current Ratio are also not provided. A large portion of assets are in trading instruments, and liabilities include short‑term borrowings, so typical leverage metrics are not shown.
Financial Health (Latest Period in Trend Context)
- Strong capital base: Shareholders’ equity grew 4.5% over the four quarters to $111.6B, and retained earnings rose 6.9%, reflecting consistent profit retention and share buybacks.
- Liquidity is robust: Cash & equivalents at Dec 2025 hit $111.7B, up 23% from March. This provides a large cushion against short‑term funding needs.
- Earnings recovery: After a soft Q2, net income rebounded sharply in Q3 and held near that level in Q4 (implied $4.4B). The full‑year earnings of $16.86B put the company on a strong annualized run rate (~$17.6B if Q3 level sustained, but Q4 dipped slightly).
- Leverage is stable: Total assets grew in line with liabilities, and equity/asset ratio remained steady at ~7.8% over the four periods (consistent with a high‑leverage business model).
- No concerning signals from the balance sheet or income statement — the company is well‑capitalized, cash‑rich, and profitable. The negative operating cash flow is normal for the industry.
Insider Activity
Coverage period: 2026-02-03 to 2026-05-04
Overall Sentiment: Neutral (−10) — predominantly sell transactions with no notable insider buying.
| Metric | Value |
|---|---|
| Total Buys | $0 (8 transactions all at $0 — likely option exercises/grants with no cash outlay) |
| Total Sells | $35,837,097.84 (22 transactions) |
| Net Insider Flow | −$35.8M |
Key Transactions (past 30 days):
- Eric Grossman (Chief Legal Officer) sold $2.12M on 2026-04-20 at $190–$191.50.
- Daniel Simkowitz (Co‑President) sold $2.78M on 2026-04-17 at $189.24, plus 8,000 shares at $0 (likely share withholding).
- Andrew Saperstein (Co‑President) sold a combined $9.74M on 2026-04-16 across six trades at prices from $187.20 to $192.12.
- Mandell Crawley (Head of Wealth Mgmt.) sold $3.04M on 2026-04-16 at $187–$189.
Interpretation: Multiple top executives have been selling significant portions of their holdings in the $187–$192 range. While insider selling is common for diversification, the concentrated selling by several key leaders over a short window, with zero cash buys, suggests a less confident view at current levels. Neutral‑to‑slightly‑bearish signal for the short term.
Multi‑Timeframe Technical Context
No intraday or multi‑timeframe price/volume data was provided for this analysis. The only reference price is the current regular‑session close of $188.68.
- Ultra‑short (minutes/hours): Cannot assess due to lack of candle data.
- Short‑term (days): The recent insider selling cluster around $187–$192 creates a potential resistance zone. Without volume and momentum data, we defer to price action patterns.
- Long‑term (weeks/months): The fundamental trajectory — rising earnings, strong capital, consistent buybacks — is supportive. The current P/E (based on full‑year EPS of $10.32) is ~18.3x, which is within the historical range for the stock.
Actionable recommendation: Incorporate the provided 1‑minute through 1‑day chart data (if available) to refine entry/exit levels.
Bull / Bear Cases
Short‑Term (Days to Weeks)
Bull Case
- Q4 implied net income of ~$4.4B shows earnings momentum remained healthy despite a slight sequential dip.
- $111.7B in cash provides a safety net; any market stress would likely see money‑center banks benefit from flight‑to‑safety flows.
- Share buybacks continue to shrink the float, mechanically supporting EPS.
Bear Case
- Insider selling by three top executives ($32M combined in one week) suggests near‑term caution at current price levels.
- The stock has rallied significantly from 2025 lows (not shown), and the Q4 earnings dip may signal a peak in the rate‑driven revenue cycle.
- Without revenue data, we cannot assess top‑line growth; if net income growth stalls, the current P/E could contract.
Long‑Term (Weeks to Months)
Bull Case
- Consistent growth in shareholders’ equity and retained earnings reinforces intrinsic value.
- The company is a diversified financial powerhouse; wealth management provides stable fee income, and investment banking could rebound with M&A/IPOs.
- Buyback trend (1.5% shrink in shares over three quarters) will compound EPS growth even if net income is flat.
Bear Case
- Interest rate environment may pressure net interest margins (not reported but relevant to broker‑dealers).
- Operating cash flow remains negative, requiring ongoing reliance on debt/equity markets.
- The broad market valuation is extended; a correction would hit MS’s trading and advisory revenues hard.
Key Levels & Triggers
| Level / Trigger | Reference |
|---|---|
| Current Price | $188.68 |
| Insider Selling Zone | $187–$192 (cluster of recent sales) |
| Key Support (psychological) | $180 (round number, also near Q2 2025 lows) |
| Key Resistance (recent) | $192 (high of insider sales on 4/20) |
| Earnings Trigger | Next quarterly report (late April 2026) — Q1 2026 results will confirm whether trajectory is accelerating or stalling. |
| Buyback Catalyst | Announcement of accelerated share repurchase would be a short‑term positive. |
| Macro Trigger | Changes in Fed rate policy or regulatory shifts in capital requirements for G‑SIBs. |
Summary: Morgan Stanley is a fundamentally sound firm with growing capital and earnings. However, the concentrated insider selling at current levels warrants caution in the near term. Long‑term investors can use any pullback toward $180–$185 as a potential entry, while short‑term traders should watch for a definitive close above $192 to signal renewed momentum.
Data as of latest provided filings. No revenue data available; margins and P/E derived from net income only. Technical analysis limited due to missing price/volume data.
